Author: Okeke, Malachy I.; Okoli, Arinze S.; Diaz, Diana; Offor, Collins; Oludotun, Taiwo G.; Tryland, Morten; Bøhn, Thomas; Moens, Ugo
Title: Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps? Document date: 2017_10_29
ID: 175igdfk_28
Snippet: Since MVA is subjected to selection pressure (multiple multiplication cycles) during production of a high titer virus stock intended for vaccination, it is essential to examine the genome stability of the virus across MSV + 1 to MSV + 5 in human cell lines and in immune-competent and immune-compromised animal models. At present, this information is not provided in ERA dossiers submitted for clinical trials or MAA because relevant EU directive (Di.....
Document: Since MVA is subjected to selection pressure (multiple multiplication cycles) during production of a high titer virus stock intended for vaccination, it is essential to examine the genome stability of the virus across MSV + 1 to MSV + 5 in human cell lines and in immune-competent and immune-compromised animal models. At present, this information is not provided in ERA dossiers submitted for clinical trials or MAA because relevant EU directive (Directive 2001/18/EC) has not made the provision of such data obligatory. Data on evolution of MVA in permissive cells during Good Manufacturing Practice (GMP) manufacturing will enable risk assessors to evaluate the genome stability of MVA and the presence of variants in the production batch intended for vaccination. The emergence of quasi-species and their role in the modulation of the MVA phenotype including host range, infectivity, attenuation, virulence and biodistribution is an omitted research field that needs to be addressed.
Search related documents:
Co phrase search for related documents- address need and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- address need and high titer: 1
- address need and host range: 1
- address need and human cell: 1, 2, 3, 4, 5, 6, 7, 8
- address need and human cell line: 1, 2, 3, 4
- address need and research field: 1, 2, 3, 4, 5
- address need and vaccination intend: 1, 2
- address need research field and research field: 1
- animal model and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9
- animal model and high titer: 1, 2, 3, 4, 5
- animal model and high titer virus: 1, 2
- animal model and host range: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- animal model and human cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- animal model and human cell line: 1, 2, 3, 4
- animal model and permissive cell: 1, 2, 3, 4, 5, 6
- animal model and research field: 1, 2
- animal model and variant presence: 1
Co phrase search for related documents, hyperlinks ordered by date